KPC Pharmaceuticals Inc 600422.SS

Last Updated: May 15, 12:00 AM·SSE

KPC Pharmaceuticals Inc

KPC Pharmaceuticals Inc. Stock Analysis 600422.SS

China Health Care Small Cap
KPC Pharmaceuticals, Inc. engages in the research, development, production and sales of natural botanical medicines. The company is headquartered in Kunming, Yunnan and currently employs 5,072 full-time employees. The company went IPO on 2000-12-06. The firm operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The firm conducts business in both domestic and overseas markets.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.